Selected research
Industry Research
Subcutaneous Allergy Immunotherapies Industry Research Report 2026
Market perspective
The global Subcutaneous Allergy Immunotherapies market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Subcutaneous Allergy Immunotherapies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Subcutaneous Allergy Immunotherapies is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Subcutaneous Allergy Immunotherapies is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Subcutaneous Allergy Immunotherapies include Merck, WOLW Pharma, Stallergenes Greer, Leti, Holister Stier, HAL, Allergy Therapeutics and ALK-Abello, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Subcutaneous Allergy Immunotherapies market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Subcutaneous Allergy Immunotherapies Market by Company
Merck
WOLW Pharma
Stallergenes Greer
Leti
Holister Stier
HAL
Allergy Therapeutics
ALK-Abello
Subcutaneous Allergy Immunotherapies Segment by Type
High Concentration
Low Concentration
Subcutaneous Allergy Immunotherapies Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Subcutaneous Allergy Immunotherapies Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Subcutaneous Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Subcutaneous Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Subcutaneous Allergy Immunotherapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Subcutaneous Allergy Immunotherapies manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Subcutaneous Allergy Immunotherapies by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Subcutaneous Allergy Immunotherapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- High Concentration
- Low Concentration
Applications
- Primary Immunodeficiency
- Secondary Immunodeficiency
- Others
Companies covered
- Merck
- WOLW Pharma
- Stallergenes Greer
- Leti
- Holister Stier
- HAL
- Allergy Therapeutics
- ALK-Abello
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Subcutaneous Allergy Immunotherapies Market Size (2021-2032)
- 2.2.2 Global Subcutaneous Allergy Immunotherapies Sales (2021-2032)
- 2.2.3 Global Subcutaneous Allergy Immunotherapies Market Average Price (2021-2032)
- 2.3 Subcutaneous Allergy Immunotherapies by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 High Concentration
- 2.3.3 Low Concentration
- 2.4 Subcutaneous Allergy Immunotherapies by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Primary Immunodeficiency
- 2.4.3 Secondary Immunodeficiency
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Subcutaneous Allergy Immunotherapies Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Subcutaneous Allergy Immunotherapies Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Subcutaneous Allergy Immunotherapies Revenue of Manufacturers (2021-2026)
- 3.4 Global Subcutaneous Allergy Immunotherapies Average Price by Manufacturers (2021-2026)
- 3.5 Global Subcutaneous Allergy Immunotherapies Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Subcutaneous Allergy Immunotherapies, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Subcutaneous Allergy Immunotherapies, Product Type & Application
- 3.8 Global Manufacturers of Subcutaneous Allergy Immunotherapies, Established Date
- 3.9 Global Subcutaneous Allergy Immunotherapies Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Subcutaneous Allergy Immunotherapies Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 WOLW Pharma
- 4.2.1 WOLW Pharma Company Information
- 4.2.2 WOLW Pharma Business Overview
- 4.2.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolio
- 4.2.5 WOLW Pharma Recent Developments
- 4.3 Stallergenes Greer
- 4.3.1 Stallergenes Greer Company Information
- 4.3.2 Stallergenes Greer Business Overview
- 4.3.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolio
- 4.3.5 Stallergenes Greer Recent Developments
- 4.4 Leti
- 4.4.1 Leti Company Information
- 4.4.2 Leti Business Overview
- 4.4.3 Leti Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Leti Subcutaneous Allergy Immunotherapies Product Portfolio
- 4.4.5 Leti Recent Developments
- 4.5 Holister Stier
- 4.5.1 Holister Stier Company Information
- 4.5.2 Holister Stier Business Overview
- 4.5.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolio
- 4.5.5 Holister Stier Recent Developments
- 4.6 HAL
- 4.6.1 HAL Company Information
- 4.6.2 HAL Business Overview
- 4.6.3 HAL Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 HAL Subcutaneous Allergy Immunotherapies Product Portfolio
- 4.6.5 HAL Recent Developments
- 4.7 Allergy Therapeutics
- 4.7.1 Allergy Therapeutics Company Information
- 4.7.2 Allergy Therapeutics Business Overview
- 4.7.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolio
- 4.7.5 Allergy Therapeutics Recent Developments
- 4.8 ALK-Abello
- 4.8.1 ALK-Abello Company Information
- 4.8.2 ALK-Abello Business Overview
- 4.8.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolio
- 4.8.5 ALK-Abello Recent Developments
5 Global Subcutaneous Allergy Immunotherapies Market Scenario by Region
- 5.1 Global Subcutaneous Allergy Immunotherapies Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2021-2032
- 5.2.1 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2021-2026
- 5.2.2 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2027-2032
- 5.3 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2021-2032
- 5.3.1 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2021-2026
- 5.3.2 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2027-2032
- 5.4 North America Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
- 5.4.1 North America Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
- 5.4.3 North America Subcutaneous Allergy Immunotherapies Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
- 5.5.1 Europe Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
- 5.5.3 Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
- 5.6.1 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
- 5.7.1 South America Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
- 5.7.3 South America Subcutaneous Allergy Immunotherapies Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Subcutaneous Allergy Immunotherapies Sales by Type (2021-2032)
- 6.1.1 Global Subcutaneous Allergy Immunotherapies Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2021-2032)
- 6.2 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2021-2032)
- 6.2.1 Global Subcutaneous Allergy Immunotherapies Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2021-2032)
- 6.3 Global Subcutaneous Allergy Immunotherapies Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Subcutaneous Allergy Immunotherapies Sales by Application (2021-2032)
- 7.1.1 Global Subcutaneous Allergy Immunotherapies Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2021-2032)
- 7.2 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2021-2032)
- 7.2.1 Global Subcutaneous Allergy Immunotherapies Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2021-2032)
- 7.3 Global Subcutaneous Allergy Immunotherapies Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Subcutaneous Allergy Immunotherapies Value Chain Analysis
- 8.1.1 Subcutaneous Allergy Immunotherapies Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Subcutaneous Allergy Immunotherapies Production Mode & Process
- 8.2 Subcutaneous Allergy Immunotherapies Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Subcutaneous Allergy Immunotherapies Distributors
- 8.2.3 Subcutaneous Allergy Immunotherapies Customers
9 Global Subcutaneous Allergy Immunotherapies Analyzing Market Dynamics
- 9.1 Subcutaneous Allergy Immunotherapies Industry Trends
- 9.2 Subcutaneous Allergy Immunotherapies Industry Drivers
- 9.3 Subcutaneous Allergy Immunotherapies Industry Opportunities and Challenges
- 9.4 Subcutaneous Allergy Immunotherapies Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst